Resultats de la cerca - BARTELS M.

PI-02: FOLLOW-UP RESULTS OF A PHASE 2 STUDY ASSESSING THE SAFETY AND EFFICACY OF MITAPIVAT TREATMENT, AN ORAL PYRUVATE KINASE ACTIVATOR, FOR UP TO 60 WEEKS IN SUBJECTS WITH SICKLE... per VAN DIJK M., RAB M., VAN OIRSCHOT B., BOS J., DERICHS C., RIJNEVELD A., CNOSSEN M., NUR E., BIEMOND B., BARTELS M., JANS J., VAN SOLINGE W., SCHUTGENS R., VAN WIJK R., VAN BEERS E.

Obtenir text complet

P-023: 2,3-DIPHOSPHOGLYCERATE DETECTION VIA DIRECT INFUSION HIGH RESOLUTION MASS SPECTROMETRY CORRELATES WITH QUANTITATIVE DETECTION IN BLOOD OF PATIENTS WITH SICKLE CELL DISEASE per VAN DER VEEN S., VAN DIJK M., JANS J., VERHOEVEN-DUIF N., VAN WIJK R., BARTELS M., MAÑÚ PEREIRA M., COLOMBATTI R., MARTELLA M., MUNARETO V., BOARO M., BARTOLLUCI P., CNOSSEN M., BIEMOND B., VAN BEERS E.

Obtenir text complet

PI-04: OXYGEN GRADIENT EKTACYTOMETRY-DERIVED BIOMARKERS ARE ASSOCIATED WITH THE OCCURRENCE OF ACUTE COMPLICATIONS IN SICKLE CELL DISEASE per RAB M., KANNE C., BOISSON C., BOS J., VAN OIRSCHOT B., HOUWING M., RENOUX C., SCHUTGENS R., BARTELS M., RIJNEVELD A., NUR E., CNOSSEN M., PHILIPPE J., FORT R., CONNES P., VAN WIJK R., SHEEHAN V., VAN BEERS E.

Obtenir text complet